Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Stock

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ET Company Participants Luiz Tiberio - IR Superintendent Carlos Piani - CEO Daniel Szlak - Financial Director, Investor Relations Conference Call Participants Luiz Tiberio Good morning, everyone. My name is Luiz Roberto Tiberio.

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, will present new findings at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting and Postgraduate Course from subgroup analyses of the primary endpoint of the pivotal Phase III clinical trial, STARS, evaluating the treatment effect of apraglutide by baseline demographics and disease-specific characteristics in adults with short bowel syndrome with intestinal failure.

Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Sabesp (SBS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

If you are looking for stocks that are well positioned to maintain their recent uptrend, Companhia de saneamento Basico Do Estado De Sao Paulo Sabesp (SBS) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Q4 2023 Earnings Call Transcript

Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Sabesp's significant steps toward privatization, including the approval of privatization guidelines and a follow-on model, have boosted confidence in the company's prospects. In Q2, Sabesp reported robust financial results, with recurring EBITDA increasing significantly year-over-year. Sabesp's current valuation, with the potential for reduced cost of capital and improved long-term operating performance as a private sector company, suggests significant upside potential.

Companhia de Saneamento Básico do Estado de São Paulo - SABESP (NYSE:SBS ) Q2 2023 Earnings Conference Call August 11, 2023 10:00 AM ET Company Participants Luiz Roberto Tiberio - Superintendent of Investor Relations Andre Salcedo - Chief Executive Officer Catia Pereira - Chief Financial Officer and Investor Relations Officer Luiz Roberto Tiberio Good morning. Welcome to the SABESP Second Quarter Earnings Release Call.